Artwork

Content provided by Doctors of MedicineNet.com. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Doctors of MedicineNet.com or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

MedicineNet.com - 2nd Day HIV / AIDS Conference (CROI) February 07, 2006

4:50
 
Share
 

Archived series ("Inactive feed" status)

When? This feed was archived on February 10, 2022 12:52 (2+ y ago). Last successful fetch was on October 09, 2017 12:43 (7y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 189091236 series 1626217
Content provided by Doctors of MedicineNet.com. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Doctors of MedicineNet.com or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Hello this is Dr. Eric Daar calling from Denver, Colorado from the 13th Conference on Retroviruses and Opportunistic Infections or CROI 2006. Update on meeting on second full day (February 7th). There were actually a series of world presentations all dealing with the related topic of treatment interruptions. Recently, a great deal of attention came to this area with the announcement of the data safety monitoring board closing one of these very important studies that was presented as a late breaker. The study was called SMART. It was a study through the CPCRA and the strategy was to determine whether you could take individuals with greater than 350 T cells and randomly assign them to either continue on their current therapy or interrupt their treatment with the plan of them restarting therapy if their CD4 count should drop to less than 250.
  continue reading

50 episodes

Artwork
iconShare
 

Archived series ("Inactive feed" status)

When? This feed was archived on February 10, 2022 12:52 (2+ y ago). Last successful fetch was on October 09, 2017 12:43 (7y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 189091236 series 1626217
Content provided by Doctors of MedicineNet.com. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Doctors of MedicineNet.com or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Hello this is Dr. Eric Daar calling from Denver, Colorado from the 13th Conference on Retroviruses and Opportunistic Infections or CROI 2006. Update on meeting on second full day (February 7th). There were actually a series of world presentations all dealing with the related topic of treatment interruptions. Recently, a great deal of attention came to this area with the announcement of the data safety monitoring board closing one of these very important studies that was presented as a late breaker. The study was called SMART. It was a study through the CPCRA and the strategy was to determine whether you could take individuals with greater than 350 T cells and randomly assign them to either continue on their current therapy or interrupt their treatment with the plan of them restarting therapy if their CD4 count should drop to less than 250.
  continue reading

50 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide